(CRNX) Crinetics - Performance -35.7% in 12m
Compare CRNX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
32.18%
#13 in Group
Rel. Strength
21.51%
#6246 in Universe
Total Return 12m
-35.74%
#78 in Group
Total Return 5y
68.56%
#20 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -12.37%
(?) Percentile in Group
12m Total Return: CRNX (-35.7%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: CRNX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CRNX
Total Return (including Dividends) | CRNX | XBI | S&P 500 |
---|---|---|---|
1 Month | 27.93% | 11.81% | 13.81% |
3 Months | -10.48% | -13.61% | -6.30% |
12 Months | -35.74% | -12.29% | 10.65% |
5 Years | 68.56% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | CRNX | XBI | S&P 500 |
1 Month | 78.3% | 72.9% | 83% |
3 Months | -67.5% | -83% | -75.3% |
12 Months | -48.4% | -51.6% | 50.1% |
5 Years | 80.1% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #93 | 14.4% | 12.4% |
3 Month | #87 | 3.62% | -4.47% |
12 Month | #77 | -26.7% | -41.9% |
5 Years | #20 | 124% | -18.9% |
FAQs
Does CRNX Crinetics outperforms the market?
No,
over the last 12 months CRNX made -35.74%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months CRNX made -10.48%, while XBI made -13.61%.
Over the last 3 months CRNX made -10.48%, while XBI made -13.61%.
Performance Comparison CRNX vs Indeces and Sectors
CRNX vs. Indices CRNX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -3.63% | 14.1% | -41.2% | -46.4% |
US NASDAQ 100 | QQQ | -3.82% | 10.6% | -41.4% | -47.4% |
US Dow Jones Industrial 30 | DIA | -4.04% | 17.9% | -40.9% | -43.5% |
German DAX 40 | DAX | -3.61% | 13.0% | -67.5% | -61.4% |
Shanghai Shenzhen CSI 300 | CSI 300 | -5.81% | 16.1% | -42.0% | -43.1% |
Hongkong Hang Seng | HSI | -6.80% | 8.0% | -49.5% | -49.4% |
India NIFTY 50 | INDA | 1.29% | 23.1% | -41.6% | -35.5% |
Brasil Bovespa | EWZ | -4.68% | 10.7% | -49.9% | -27.4% |
CRNX vs. Sectors CRNX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -4.27% | 14.5% | -48.2% | -57.3% |
Consumer Discretionary | XLY | -4.01% | 13.7% | -40.2% | -50.0% |
Consumer Staples | XLP | -2.77% | 21.3% | -48.1% | -44.9% |
Energy | XLE | -3.45% | 21.2% | -34.6% | -26.3% |
Financial | XLF | -4.73% | 14.4% | -48.3% | -58.2% |
Health Care | XLV | -0.62% | 27.1% | -36.2% | -31.7% |
Industrial | XLI | -5.32% | 11.1% | -42.6% | -46.7% |
Materials | XLB | -3.43% | 14.4% | -36.3% | -30.5% |
Real Estate | XLRE | -2.31% | 16.4% | -41.9% | -51.2% |
Technology | XLK | -4.71% | 6.71% | -38.3% | -42.8% |
Utilities | XLU | -3.68% | 18.3% | -48.8% | -53.2% |
Aerospace & Defense | XAR | -5.61% | 6.77% | -52.7% | -63.1% |
Biotech | XBI | 2.96% | 16.1% | -21.0% | -23.5% |
Homebuilder | XHB | -4.10% | 16.5% | -28.0% | -28.2% |
Retail | XRT | -5.53% | 13.3% | -36.9% | -34.3% |